In...India, Novartis provides Glivec totally free of charge to …99% of all patients receiving the medicine...Worldwide to…more than 17,000 patients…[T]he generic versions of Glivec in India are priced at approximately 4.5 times the average annual income...Helping patients and promoting access begins with developing new and innovative medicines …and the best way to encourage innovation is by respecting intellectual property.